MeiraGTx Holdings PLC
Change company Symbol lookup
Select an option...
MGTX MeiraGTx Holdings PLC
LOTZ Carlotz Inc
NVSAW New Vista Acquisition Corp *W EXP 02/01/2026
ARAY Accuray Inc
GE General Electric Co
NRG NRG Energy Inc
CYD China Yuchai International Ltd
FST FAST Acquisition Corp
AAPL Apple Inc

Health Care : Biotechnology | Small Cap Growth
Company profile

MeiraGTx Holdings plc is a clinical-stage gene therapy company. The Company develops gene therapy treatments for a range of inherited and acquired disorders. It is focused on developing therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia, radiation treatment for head and neck cancers and neurodegenerative diseases, such as amyothrophic lateral sclerosis (ALS). It is also developing transformative technology to enable the use of small molecules to turn gene therapy product candidates on and off. It is focused on three areas of unmet medical needs, including inherited retinal diseases, severe forms of xerostomia and neurodegenerative diseases. Its product candidates include AAV-CNGB3, AAV-CNGA3, AAV-RPGR, AAV-RPE65, AAV-AQP1 and AAV-UPF1.


Last Trade
-0.02 (-0.10%)
B/A Size

Market Hours

Closing Price
Day's Change
-0.01 (-0.05%)
Bid close
Ask close
B/A Size
Day's High
Day's Low

10-day average volume:

Analyst forecasts tech stock rebound of at least 10% and says rate fears will soon pass

10:06 am ET October 5, 2021 (MarketWatch)

By Steve Goldstein

Tech stocks seem to be falling off the rails of late, with the Nasdaq Composite slumping Monday to take the benchmark index 7% below its record high.

To closely followed tech analyst Dan Ives of Wedbush Securities, this is just a "white knuckle moment" that will soon pass. Ives says the worries around rising yields and growth stock valuations will give way to a year-end rally of at least 10% in the tech space.

"While the long standing bears will continue to yell fire into a crowded theater on a 20 bps move in the 10-year , we instead focus on the $2 trillion digital transformation opportunity across the enterprise and consumer ecosystem over the coming years that is on tech's doorstep," he said in a note to clients.

"While the valuation debate will continue to be front and center in a rising rate environment, we fundamentally believe the Street is massively underestimating what the tech growth picture looks like into 2022 and thus remain a core tenet of our unwavering tech bull thesis with this another pound the table moment to own tech stocks."

Ives concedes that the pandemic led to "a massive pull forward" in demand for cloud, e-commerce, cyber security and other tech companies. But he said it's way too early to throw in the white towel and said investors should double down.

Apple (AAPL)is Wedbush's favorite of the FAANG stocks, as he cited Microsoft (MSFT), DocuSign (DOCU), Matterport (MTTR) and Pegasystems (PEGA) as favorite cloud stocks. In cybersecurity, Wedbush favorites are Varonis Systems (VRNS), Zscaler (ZS), Telos (TLS), SailPoint Technologies (SAIL), Tenable Holdings (TENB), Palo Alto Networks (PANW) and Fortinet (FTNT).

-Steve Goldstein


(END) Dow Jones Newswires

October 05, 2021 10:06 ET (14:06 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.